Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helsinn Healthcare SA

https://www.helsinn.com/public/

Latest From Helsinn Healthcare SA

Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances

Neuroscience and oncology fuel high hopes for therapeutic R&D progress among 90-plus surveyed biopharma industry leaders.

Scrip Asks Research & Development

BridgeBio’s Achondroplasia Data Portend Competition With BioMarin’s Voxzogo

Already planning to position infigratinib as a safer, more convenient oral therapy for dwarfism compared with the BioMarin injectable, BridgeBio now has Phase II efficacy data showing a higher growth rate.

Clinical Trials Rare Diseases

Scrip Asks…What Does 2023 Hold For Biopharma? Part 7: Clinical Trial Trends

From synthetic data to real-world data, from patient engagement to patient stratification, from combination trials to master protocols and from fully decentralized through hybrid to onsite trials, the world of clinical development is undergoing major changes. Fifty executives share their predictions around clinical trial trends for the year ahead.

Scrip Asks Clinical Trials

Pfizer Ibrance India Case: ‘Willful Contempt’ Lands Local Firm In Soup

An Indian court has directed a local firm to pay a specified sum to Pfizer for contempt of court in a case pertaining to its patent on palbociclib, failing which its senior executive could face a two-week prison term.

India Commercial
See All

Company Information

  • Industry
  • Distributors
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Nutraceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Sapphire Therapeutics
    • Helsinn Pharmaceuticals Beijing Co. Ltd.
UsernamePublicRestriction

Register